clemastine has been researched along with Demyelinating Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Liu, Q; Sheng, J; Tang, X; Zhao, Y; Zhu, S | 1 |
| Huang, JK; Kouki, T; Ohno, N; Osanai, Y; Yamazaki, R | 1 |
| Gao, C; Ge, X; Ma, Y; Pan, S; Tang, J; Wang, Y; Xie, D; Zhu, Y | 1 |
| Caganap, SD; Chan, JR; Cree, BAC; Dao, DQ; Fancy, SPJ; Franklin, RJM; Henry, RG; Hoi, KK; Mei, F; Niu, J; Shen, YA; Ullian, EM; Xiao, L; Zhao, C; Zollinger, DR | 1 |
| Chen, B; Duncan, I; Heidari, M; Ikonomidou, C; Li, L; Noguchi, KK; Turski, CA; Turski, GN; Wang, H; Westmark, C | 1 |
| Fan, S; He, Y; Li, Z; Sun, B | 1 |
6 other study(ies) available for clemastine and Demyelinating Diseases
| Article | Year |
|---|---|
Clemastine Rescues Chemotherapy-Induced Cognitive Impairment by Improving White Matter Integrity.
Topics: Animals; Chemotherapy-Related Cognitive Impairment; Clemastine; Corpus Callosum; Cuprizone; Demyelinating Diseases; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendroglia; White Matter | 2022 |
Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice.
Topics: Animals; Clemastine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Internal Capsule; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Remyelination | 2023 |
Clemastine improves hypomyelination in rats with hypoxic-ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway.
Topics: Animals; Clemastine; Demyelinating Diseases; Histamine H1 Antagonists; Hypoxia-Ischemia, Brain; Interleukin-1beta; Male; Microglia; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |
Clemastine rescues myelination defects and promotes functional recovery in hypoxic brain injury.
Topics: Action Potentials; Animals; Animals, Newborn; Cell Differentiation; Cells, Cultured; Cerebellum; Clemastine; Demyelinating Diseases; Disease Models, Animal; Gene Expression Regulation, Developmental; Histamine H1 Antagonists; Humans; Hypoxia, Brain; Male; Mice; Mice, Knockout; Middle Aged; Myelin Sheath; Oligodendrocyte Precursor Cells; Optic Nerve; Oxygen; Receptor, Muscarinic M1; Recovery of Function | 2018 |
Clemastine effects in rat models of a myelination disorder.
Topics: Animals; Animals, Genetically Modified; Animals, Newborn; Blood-Brain Barrier; Brain; Cell Differentiation; Central Nervous System; Central Nervous System Diseases; Clemastine; Demyelinating Diseases; Disease Models, Animal; Genotype; Injections, Subcutaneous; Male; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Optic Nerve; Phenotype; Rats; Spinal Cord | 2018 |
Clemastine rescues behavioral changes and enhances remyelination in the cuprizone mouse model of demyelination.
Topics: Animals; Behavior, Animal; Brain; Cell Differentiation; Clemastine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Exploratory Behavior; Male; Mice; Mice, Inbred C57BL; Motor Activity; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Schizophrenia | 2015 |